Exchange: NASDAQ·Updated 12:19 PM EDT
OPT logo

OPT Opthea Limited - ADR

$0.0232
$0.0012
(5.46%)
Today
Reported EarningsFeb 27
Mkt Cap$3.97M
Vol2.00

About OPT

Ceryvyn Therapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. The company was founded by Dr. Megan Baldwin on October 17, 1984, and is headquartered in Melbourne, Australia.
50

Neutral Sentiment

How do you feel about OPT?

Advertisement|Remove ads.